Literature DB >> 2386792

Induction of stable transcriptional blockage sites by adriamycin: GpC specificity of apparent adriamycin-DNA adducts and dependence on iron(III) ions.

C Cullinane1, D R Phillips.   

Abstract

Initiated transcription complexes were exposed to adriamycin for up to 48 h. Subsequent elongation of the transcription complex revealed the presence of a series of discrete long-lived blockage sites. The mole fraction of blocked transcripts increased linearly with reaction time, adriamycin concentration, and Fe(III) concentration. Optimal conditions for formation of the blocked transcript were 24-h reaction time, 10 microM adriamycin, and 75 microM Fe(III) ions. Nine high-intensity blocked transcripts were observed, and all correspond to transcription proceeding up to G of GpC sequences of the nontemplate strand. The presence of 75 microM Fe(III) ions enhanced the amount of transcriptional blockages by 12-15-fold. Two blocked transcripts decayed with a half-life of 0.32 and 1.9 h, and one of these exhibited 100% effective delayed termination 6 bp downstream of the original blockage site. All other blockages were unchanged after 3 h of elongation. Bidirectional transcription footprinting was used to define the physical size of the drug-induced blocking moiety as a maximum of 2 bp, and this was observed at all three GpC elements probed by RNA polymerase from both directions. The nature of the apparent covalent adducts has not yet been established but is probably a G-specific adduct deriving from a reduced form of the drug (quinone methide). Although the GpC specificity suggests an interstrand G-drug-G cross-link, these were not detected by heat denaturation and subsequent denaturing gel electrophoresis of the end-labeled promoter fragment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386792     DOI: 10.1021/bi00475a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  An in vitro transcription assay for probing drug-DNA interactions at individual drug sites.

Authors:  D R Phillips; C M Cullinane; D M Crothers
Journal:  Mol Biotechnol       Date:  1998-08       Impact factor: 2.695

2.  Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts.

Authors:  B S Parker; S M Cutts; C Cullinane; D R Phillips
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

3.  Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells.

Authors:  C Cullinane; S M Cutts; C Panousis; D R Phillips
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

4.  The use of bidirectional transcription footprinting to detect platinum-DNA crosslinks by acridine-tethered platinum diamine complexes and cisplatin.

Authors:  C Cullinane; G Wickham; W D McFadyen; W A Denny; B D Palmer; D R Phillips
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

5.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

6.  Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice.

Authors:  Qi-Yuan Liu; Benny K H Tan
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

7.  Formation of adriamycin--DNA adducts in vitro.

Authors:  C Cullinane; S M Cutts; A van Rosmalen; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

8.  Molecular basis of nitrogen mustard effects on transcription processes: role of depurination.

Authors:  A Masta; P J Gray; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

9.  Response to adriamycin of transplasma membrane electron transport in adriamycin-resistant and nonresistant HL-60 cells.

Authors:  D J Morré; D M Morré; L Y Wu
Journal:  J Bioenerg Biomembr       Date:  1994-02       Impact factor: 2.945

10.  CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.

Authors:  Benny J Evison; Rebecca A Bilardi; Francis C K Chiu; Gabriella Pezzoni; Don R Phillips; Suzanne M Cutts
Journal:  Nucleic Acids Res       Date:  2009-08-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.